Gian Life Care Ltd.

As of December 31, 2025, Gian Life Care Ltd. carries a market capitalization of 86.66M, placing it among publicly traded companies globally. Its enterprise value stands at 86.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Gian Life Care Ltd. has 10.34M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Gian Life Care Ltd. trades at an EV/EBITDA multiple of 63.68 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.30 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 86.66M versus a market cap of 86.66M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of December 31, 2025.

These figures cover the twelve months ended December 31, 2025. The company generates approximately 1.57M in revenue per employee across its workforce of 24.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended December 31, 2025, Gian Life Care Ltd. recorded an income tax benefit of -819,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -10.35M and -9.53M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Gian Life Care Ltd.'s stock has declined approximately 66.75% over the past 52 weeks. The 50-day moving average sits at 4.69, while the 200-day moving average is 6.36.

Over the twelve months ended December 31, 2025, Gian Life Care Ltd. generated 37.63M in revenue and converted that into -9.53M in net income, yielding earnings per share of -0.92. EBITDA reached 1.36M, while operating income came in at -4.68M.

Over the twelve months ended December 31, 2025, Gian Life Care Ltd. posted a gross margin of 74.72, reflecting its pricing power and cost economics. The operating margin of -12.44 and net profit margin of -25.34 provide insight into operational efficiency.

Gian Life Care Ltd.'s most recent stock split took place on March 29, 2022 with a 5:11 split ratio.